NASDAQ · Biotechnology

BELLUS Health Inc. (BLU) Stock

$14.75 +0.03% NASDAQ: BLU Healthcare

BELLUS Health Inc. is a clinical-stage biopharmaceutical company headquartered in Laval, Canada, and founded in 1993.

Valuation

MetricValue
Price$14.75
Market Cap$1.87B
P/E Ratio-22.34
P/B Ratio4.35
P/S Ratio116865.18
EPS (TTM)$-0.66
52-Week High$14.76
52-Week Low$6.38
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-22.28%
ROA-18.66%
ROCE-19.87%
Gross Margin—
Operating Margin—
Net Margin—
Debt/Equity0.00
Current Ratio22.42

Annual Financials (USD)

Metric20182019202020212022
Revenue$0$0$0$0$0
Operating Profit$-7.0M$-26.0M$-33.0M$-73.0M$-78.0M
Net Profit$-6.0M$-26.0M$-32.0M$-71.0M$-76.0M
EPS$-0.18$-0.49$-0.54$-0.90$-0.66
Op Margin-28303.9%-97431.6%-219613.3%-458025.0%-486768.8%

Balance Sheet (USD)

Metric20182019202020212022
Total Assets$39.0M$96.0M$153.0M$310.0M$408.0M
Total Liabilities$2.0M$8.0M$6.0M$18.0M$17.0M
Cash$11.0M$19.0M$49.0M$150.0M$87.0M
Borrowings$0$0$1.0M$1.0M$1.0M

Latest News

BDC Dividends Face a Reckoning As Fed Rate Cuts Squeeze Earnings 24/7 Wall St. · Jul 13, 2026 5 Income Stocks Yielding 10%+ with Dividends in Danger 24/7 Wall St. · Jul 9, 2026 Trump Financial Disclosure Shows 21,000 Trades in 2025 Bloomberg · Jul 2, 2026 Blue Owl Capital Corporation Schedules Earnings Release and Quarterly Earnings Call to Discuss its Second Quarter Ended June 30, 2026 Financial Results PR Newswire · Jul 1, 2026 Blue Owl Capital (OBDC) Stock Fair Value Falls As Analysts Cut Targets On Yield Pressure Simply Wall St. · Jun 27, 2026

Cash Flow (USD)

Metric20182019202020212022
Operating Cash Flow$-7.0M$-21.0M$-30.0M$-61.0M$-77.0M
Investing Cash Flow$-12.0M$-49.0M$22.0M$-57.0M$-169.0M
Financing Cash Flow$24.0M$73.0M$29.0M$210.0M$162.0M
Net Cash Flow$5.0M$7.0M$30.0M$101.0M$-63.0M
Free Cash Flow$-7.0M$-25.0M$-30.0M$-70.0M$-98.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.86
EV / EBITDA-24.52
FCF Yield-5.24%
Quick Ratio22.42
Interest Coverage-998.50
Return 1Y—
Return 3Y—
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AMAMAmbrx Biopharma Inc. $28.00 +0.07% -13.86 $1.77B 0.00%
ASTH $36.33 -0.51% 63.95 $1.80B 0.00%
CALTCalliditas Therapeutics AB (publ) $40.00 -0.10% -22.08 $2.15B 0.00%
CINCCinCor Pharma, Inc. $29.06 +0.00% -20.46 $1.27B 0.00%
CTICCTI BioPharma Corp. $9.10 +0.06% -11.51 $1.20B 0.00%

About BELLUS Health Inc.

BELLUS Health Inc. is a clinical-stage biopharmaceutical company headquartered in Laval, Canada, and founded in 1993. The firm focuses on developing therapeutic solutions for refractory chronic cough (RCC) and other related cough hypersensitivity conditions. Its leading product candidate, BLU-5937, an antagonist designed to block the P2X3 receptor, is currently progressing through Phase II clinical trials for the treatment of both RCC and chronic pruritus.

BELLUS Health Inc. is headquartered in CA.

BELLUS Health Inc. (BLU) stock trades at $14.75 with a market capitalization of $1.87B. The stock is valued at a price-to-earnings (P/E) ratio of -22.34, price-to-book of 4.35, price-to-sales of 116865.18. Over the past 52 weeks the stock has ranged between $6.38 and $14.76, and currently trades at its 52-week high.

On profitability, BELLUS Health Inc. generates a return on equity (ROE) of -22.28%, return on capital employed of -19.87%.

Official website: www.bellushealth.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides